Allergen-derived peptide: A promising approach in asthma - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Revue des Maladies Respiratoires Year : 2019

Allergen-derived peptide: A promising approach in asthma


Severe asthma required high dose of corticosteroids combined with biotherapies to control more or less asthma symptoms and lead to the decrease of patients' quality of life on long term. Recent studies show that hypoallergenic peptides derived from allergen can prevent airway hyperresponsiveness, decrease Th2 response and also allergen-specific IgE in mouse models of allergic asthma. Even if some peptides mechanisms remain unknown, their fast efficacy with low doses of allergens make peptide immunotherapy a new promising approach in allergic asthma.
Fichier principal
Vignette du fichier
S0761842519300841.pdf (224.93 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02619077 , version 1 (22-10-2021)


Attribution - NonCommercial



M. Klein, Axel Magnan, Grégory Bouchaud. Allergen-derived peptide: A promising approach in asthma. Revue des Maladies Respiratoires, 2019, 36 (4), pp.442-446. ⟨10.1016/j.rmr.2019.03.005⟩. ⟨hal-02619077⟩
15 View
22 Download



Gmail Facebook Twitter LinkedIn More